ULTIMATE IMMORTALS
Natural health product licensed in Canada
- Other names
- ER ZHI XIAN FANG
- Licence holder
- Eastern Currents Ltd.
- NPN or DIN-HM
- 80036130
- Status
- Inactive licence
- Licence date
- 3 October 2012
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Traditionnelle
If this product were sold in France
- Conditions légales
Phellodendron amurense Rupr.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux femmes enceintes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Albizia julibrissin Durazz.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux femmes enceintes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Glycyrrhiza uralensis Fisch.: La portion journalière recommandée ne doit pas conduire à une ingestion d'acide glycyrrhizinique supérieure à 100 mg. L'étiquetage doit comporter un avertissement avec la teneur suivante: "Ne pas utiliser pendant plus de 6 semaines sans avis médical." L'étiquetage doit comporter un avertissement déconseillant l'emploi chez les enfants.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Ginseng (Panax ginseng) Source : Racine Extraction ratio : 10:1 Dry plant equivalent : 150 mg | 15 mg | Not calculated |
| Phellodendron amurense Source : Écorce (tige) Extraction ratio : 10:1 Dry plant equivalent : 230 mg | 23 mg | Not calculated |
| Ziziphus jujuba Source : Fruit Extraction ratio : 10:1 Dry plant equivalent : 310 mg | 31 mg | Not calculated |
| Eclipta prostrata Source : Sommité Extraction ratio : 10:1 Dry plant equivalent : 310 mg | 31 mg | Not calculated |
| Albizia Julibrissin Source : Écorce (tige) Extraction ratio : 10:1 Dry plant equivalent : 310 mg | 31 mg | Not calculated |
| Epimedium grandiflorum Source : Plante Extraction ratio : 10:1 Dry plant equivalent : 230 mg | 23 mg | Not calculated |
| Triticum aestivum Source : Graine(s) Extraction ratio : 10:1 Dry plant equivalent : 530 mg | 53 mg | Not calculated |
| Crassostrea gigas Source : Shell Extraction ratio : 10:1 Dry plant equivalent : 310 mg | 31 mg | Not calculated |
| Melia azedarach Source : Fruit Extraction ratio : 10:1 Dry plant equivalent : 230 mg | 23 mg | Not calculated |
| Glycyrrhiza uralensis Source : Racine Extraction ratio : 10:1 Dry plant equivalent : 230 mg | 23 mg | Not calculated |
Non-medicinal ingredients
Gélatine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 3 Capsule | 2 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Product manufactured based on traditional Chinese medicine theory.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80036130
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.